Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Clinical trial NCT07502495 · RECRUITING
Trial details
- NCT number
- NCT07502495
- Sponsor
- Biomea Fusion Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2027-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.